96818 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO
#2Antigens for Detection of Early Lyme Disease
#3Panel comprising Borrelia MHC multimers
#4BORRELIA IMMUNOASSAYS AND MATERIALS THEREFOR
#5NANOSTRUCTURE-FORMING POLYPEPTIDES AND USES THEREOF
#6VACCINE AGAINST LEPTOSPIROSIS
#7MULTIVALENT OSPA POLYPEPTIDES AND METHODS AND USES RELATING THERETO
#8Antigenic OspA Polypeptides
#9COMPOSITIONS AND METHODS FOR DIAGNOSING LYME DISEASE AND FOR PREDICTING LYME DISEASE SPIROCHETE ELIMINATION AFTER TREATMENT
#10FUSION PROTEIN FOR DETECTING NEUROSYPHILIS AND KIT THEREOF
#11SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY
#12CHIMERIC RECOMBINANT PROTEINS AND RECOMBINANT PROTEIN PANELS FOR THE DIAGNOSIS OF LYME DISEASE IN ANIMALS AND HUMANS
#13VARIANTS OF CAS12A NUCLEASES AND METHODS OF MAKING AND USE THEREOF
#14VARIANTS OF CAS12A NUCLEASES AND METHODS OF MAKING AND USE THEREOF
#15MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO
#16MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO
#17PEPTIDES AND METHODS FOR THE DETECTION OF LYME DISEASE ANTIBODIES
#18METHOD FOR IMPROVING ANTIGEN IMMUNOGENICITY, CORONAVIRUS ANTIGEN, USE THEREOF, RECOMBINANT VECTOR, EXPRESSION KIT, TRANSGENIC CELL LINE, RECOMBINANT BACTERIUM, CORONAVIRUS VACCINE, PREPARATION METHOD OF ANTIGEN AND NUCLEOTIDE SEQUENCE
#19LEPTOSPIRAL PROTEINS AND USES THEREOF
#20Multivalent OspA polypeptides and methods and uses relating thereto
#21SPECIES-SPECIFIC ANTIGEN SEQUENCES FOR TICK-BORNE RELAPSING FEVER (TBRF) AND METHODS OF USE
#22Mutant fragments of OspA and methods and uses relating thereto
#23immunoassays and materials therefor
#24Panel comprising MHC multimers
#25Compositions and methods for diagnosing Lyme disease and for predicting Lyme disease spirochete elimination after treatment
#26Insecticidal proteins
#27SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY
#28Peptides and methods for the detection of Lyme disease antibodies
#29Variants of CAS12A nucleases and methods of making and use thereof
#30VMP-LIKE SEQUENCES OF PATHOGENIC BORRELIA SPECIES AND STRAINS
#31Mutant fragments of OspA and methods and uses relating thereto
#32MHC Multimers in Borrelia Diagnostics and Disease
#33Antigenic OspA polypeptides
#34Mutant fragments of OspA and methods and uses relating thereto
#35Surface display of antigens on Gram-negative outer membrane vesicles
#36DbpA antibodies and uses thereof
#37VMP-like sequences of pathogenic species and strains
#38Insecticidal proteins
#39Compositions and methods for diagnosing Lyme disease and for predicting Lyme disease spirochete elimination after treatment
#40DNA ANTIBODY CONSTRUCTS FOR USE AGAINST LYME DISEASE
#41Safe potent single platform vaccine against Tier 1 select agents and other pathogens
#42immunoassays and materials therefor
#43Vaccine strains of brachyspira hyodysenteriae
#44Peptides and methods for the detection of Lyme disease antibodies
#45Mutant fragments of OspA and methods and uses relating thereto
#46Mutant fragments of OspA and methods and uses relating thereto
#47Chimeric OspA genes, proteins and methods of use thereof
#48Polyvalent chimeric OspC vaccinogen and diagnostic antigen
#49Live attenuated heterologous vaccine for
#50PROTEINS USED FOR THE DIAGNOSIS OF LYME BORRELIOSIS
#51Strings of epitopes useful in diagnosing and eliciting immune responses to sexually transmitted infections
#52Surface display of antigens on gram-negative outer membrane vesicles
#53Treponema pallidum triplet antigen
#54VMP-like sequences of pathogenic species and strains
#55Peptides and methods for the detection of lyme disease antibodies
#56Nucleic acids, vectors, host cells, and methods for recombinantly producing water-soluble membrane proteins
#57Stage specific diagnostic antigens, assay and vaccine for lyme disease
#58Recombinant Borrelia Proteins And Methods Of Use Thereof
#59Proteins used for the diagnosis of lyme borreliosis
#60Lyme disease vaccine
#61Mutant fragments of OspA and methods and uses relating thereto
#62Mutant fragments of OspA and methods and uses relating thereto
#63Proteins with repetitive bacterial-IG-like (Big) domains present in species
#64Mutant fragments of OspA and methods and uses relating thereto
#65Peptides for diagnosing lyme disease
#66VMP-LIKE SEQUENCES OF PATHOGENIC BORRELIA
#67Method, kits and materials for detection of Lyme disease sp. infection
#68Chimeric OspA genes, proteins and methods of use thereof
#69Proteins with repetitive bacterial-IG-like (BIG) domains present in species
#70OspA Fusion Protein for Vaccination against Lyme Disease
#71Immunogenic TP0751 fragments
#72Treponema pallidum triplet antigen
#73Peptides and methods for the detection of lyme disease antibodies
#74VMP-like sequences of pathogenic species and strains
#75Vaccines and methods to treat lyme disease in dogs
#76Oral Vaccine For Borrelia
#77NOVEL GENES AND PROTEINS OF BRACHYSPIRA HYODYSENTERIAE AND USES THEREOF
#78Strings of epitopes useful in diagnosing and eliciting immune responses to sexually transmitted infections
#79Recombinant outer membrane proteins from and uses thereof
#80Proteins with repetitive Bacterial-Ig-like (Big) domains present in species
#81MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO
#82MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO
#83Soluble immunoreactive treponema pallidum TpN47 antigens
#84Polyvalent chimeric OSPC vaccinogen and diagnostic antigen
#85Polyvalent chimeric OspC vaccinogen and diagnostic antigen
#86Proteins used for the diagnosis of lyme borreliosis
#87Diagnostic peptides for lyme disease
#88Peptides and methods for the detection of lyme disease antibodies
#89Isolated Brachyspira and Methods and Compositions for Expanding and Isolating Brachyspira
#90VACCINES AND METHODS TO TREAT LYME DISEASE IN DOGS
#91Proteins with repetitive bacterial-Ig-like (Big) domains present in species
#92RECOMBINANT PROTEINS FOR USE IN VACCINE, ANTIBODIES AGAINST SAID PROTEINS, AND DIAGNOSTIC AND THERAPEUTIC METHODS INCLUDING THE SAME
#93VMP-like sequences of pathogenic species and strains
#94Lyme disease vaccine
#95SOLUBLE TREPONEMA PALLIDUM PROTEIN TP0453, TP0453-TP0326 FUSION PROTEIN, AND USE IN SYPHILIS DIAGNOSIS
#96Immunogenic proteins of
#97Treponema pallidum triplet antigen
#98Chimeric OspA proteins and methods of use thereof
#99Chimeric OspA genes, proteins and methods of use thereof
#100Altered OspA of
#101Mutant fragments of OspA and methods and uses relating thereto
#102Sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
#103Methods for diagnosing lyme disease
#104Polyvalent chimeric OspC vaccinogen and diagnostic antigen
#105VACCINES
#106Vmp-like sequences of pathogenic
#107Proteins with repetitive bacterial-Ig-like (Big) domains present in leptospira species
#108IMMUNOGENIC PROTEINS FROM GENOME-DERIVED OUTER MEMBRANE OF LEPTOSPIRA AND COMPOSITIONS AND METHODS BASED THEREON
#109Reagent for assaying anti-treponema pallidum antibody
#110Peptides and methods for the detection of lyme disease antibodies
#111VMP-like sequences of pathogenic borrelia species and strains
#112Proteins with repetitive bacterial-Ig-like (Big) domains present in species
#113triplet antigen
#114antigens
#115Proteins used for the diagnosis of lyme borreliosis
#116Proteins used for the diagnosis of lyme borreliosis
#117VMP-like sequences of pathogenic
#118Proteins with repetitive Bacterial-Ig-like (Big) domains present in species
#119IMMUNOGENIC PROTEINS FROM GENOME-DERIVED OUTER MEMBRANE OF LEPTOSPIRA AND COMPOSITIONS AND METHODS BASED THEREON
#120VMP-like sequences of pathogenic species and strains
#121Chimeric OspA genes, proteins, and methods of use thereof
#122Proteins with repetitive bacterial-Ig-like (Big) domains present in species
#123Chimeric OspA genes, proteins, and methods of use thereof
#124LYME DISEASE VACCINE
#125BORRELLIA BURGDORFERI BACTERIN
#126Proteins with repetitive Bacterial-Ig-like (Big) domains present in species
#127VMP-like sequences of pathogenic species and strains
#128Immunogenic proteins of
#129Polyvalent chimeric OspC vaccinogen and diagnostic antigen
#130NOVEL SEQUENCES OF BRACHYSPIRA, IMMUNOGENIC COMPOSITIONS, METHODS FOR PREPARATION AND USE THEREOF
#131Sequences of , immunogenic compounds, methods for preparation and use thereof
#132Genes and proteins of and uses thereof
#133VMP-like sequences of pathogenic
#134NOVEL GENES AND PROTEINS OF BRACHYSPIRA HYODYSENTERIAE AND USE OF SAME FOR DIAGNOSIS AND THERAPY
#135Immunogenic Compositions and Methods for Treating and Preventing Animal Infections
#136Proteins with repetitive Bacterial-Ig-like (Big) domains present in species
#137antigens
#138BRACHYSPIRA PILOSICOLI 72kDa OUTER-MEMBRANE PROTEIN AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
#139Split-core-particles for the presentation of foreign molecules, especially for vaccine applications, and method for their production
#140Altered OspA of
#141Oral vaccine for
#142Peptide diagnostic agent for lyme disease
#143Groups Of Borrelia Burgdorferi And Borrelia Afzelii That Cause Lyme Disease In Humans
#144Detection of primary infections with pathogens
#145Surface protein of leptospira
#146Novel Brachyspira hyodysenteriae vaccine
#147Method of purification of hydrophobic proteins
#148COMPOSITIONS AND METHODS FOR DETECTING TREPONEMA PALLIDUM
#149Immunological combination compositions and methods
#150vaccine
#151BORRELIA BURGDORFERI BACTERIN
#152Peptides for preventing, diagnosing and treating animal and/or human leptospirosis
#153Polyvalent chimeric OspC vaccinogen and diagnostic antigen
#154Innate immune system-directed vaccines
#155VMP-like sequences of pathogenic
#156Proteins with repetitive bacterial-Ig-like (big) domains present in species
#15772 kDa outer-membrane protein and diagnostic and therapeutic uses thereof
#158Recombinant constructs of
#159Compositions and methods for treatment of chronic and infectious diseases
#160Carrier and method for the detection of anti-borrelia antibodies and test kit for use in the diagnosis of Lyme borreliosis infections
#161Surface protein of
#162Vaccine compositions for prevention of chronic and infectious diseases
#163Diagnosis and treatment of Alzheimer disease
#164METHOD FOR REDUCING LYSOZYME ENZYMATIC ACTIVITY
#165Surface protein of
#166VMP-like sequences of pathogenic species and strains
#167Surface proteins of
#168Sources for, and types of, insecticidally active proteins, and polynucleotides that encode the proteins
#169Groups of and that cause Lyme Disease in humans
#170Means and methods for diagnosing a treponema infection
#171Novel brachyspira hyodyseteriae vaccine
#172Immunological combination compositions and methods
#173Compositions and methods for detecting pathogen infection
#174BmpB novel nucleotide and amino acid sequences and diagnostic and therapeutic uses thereof
#175Compositions and methods for detecting
#176Surface protein of Leptospira
#177Compositions and kits for detecting pathogen infection
#178Recombinant constructs of
#179Immunogenic proteins of
#180Surface proteins of
#181Surface proteins of
#182Compositions and methods for detecting
#183Optical recording apparatus using one-dimensional diffractive light modulator
#184Diagnostic tests for a new spirochete, Borrelia lonestari sp. nov.
#185Brachyspira hyodysenteriae vaccine
#186Lyme disease vaccines
#187Borrelia burgdorferi bacterin
#188Surface proteins of leptospira
#189Chimeric recombinant proteins and recombinant protein panels for the diagnosis of Lyme disease in animals and humans
#190Serodiagnosis of Lyme disease by use of two recombinant proteins in ELISA
#191Serodiagnosis of lyme disease by use of two recombinant proteins in ELISA